P&G Hygiene and Health Care]( https://scanx.trade/company/procter-gamble-hygiene-health-care-ltd ) delivered a strong financial performance in Q3FY26, demonstrating resilience in its core health and hygiene products business. The company's net profit grew 12.2% year-on-year to ₹301.46 crore for the quarter ended December 31, 2025, compared to ₹268.59 crore in the corresponding quarter of the previous year.

Financial Performance Overview

The company's quarterly results showed mixed revenue performance with marginal growth in overall operations. Revenue from operations increased by 1.1% to ₹1,261.90 crore in Q3FY26 from ₹1,247.63 crore in Q3FY25. However, the nine-month performance painted a more robust picture with significant profit growth.

Nine-Month Performance Highlights

The company's nine-month performance for FY26 demonstrated strong operational efficiency and profitability improvements. Net profit for the nine months ended December 31, 2025, surged 25.3% to ₹703.37 crore compared to ₹561.55 crore in the corresponding period last year.

Dividend Declaration and Corporate Actions

The Board of Directors approved a substantial interim dividend for FY26, reflecting the company's strong cash generation and commitment to shareholder returns. The interim dividend of ₹195 per equity share includes a regular dividend component and a one-time special dividend of ₹25 per share.

Operational and Cost Management

The company demonstrated effective cost management across various expense categories. Employee benefits expense decreased to ₹61.67 crore in Q3FY26 from ₹66.17 crore in Q3FY25. Advertising and sales promotion expenses were optimized at ₹145.48 crore compared to ₹158.34 crore in the previous year quarter, indicating strategic marketing spend management.

Business Segments and Future Outlook

P&G Hygiene and Health Care operates in two primary segments: Health Care Products comprising ointments, creams, cough drops and tablets, and Hygiene Products including feminine hygiene products and other skin care hygiene items. The company has aggregated these segments into a single reportable segment focused on manufacturing, trading and marketing of health and hygiene products.

The company continues to monitor regulatory changes, particularly the implementation of the new Labour Codes effective from November 21, 2025, though management expects minimal financial impact given the current salary structure's alignment with new requirements.

P&G Hygiene and Health Care has announced that its board of directors will convene on January 30, 2026, to consider the declaration of an interim dividend for the Financial Year 2025-26. The company made this disclosure through a regulatory filing dated January 21, 2026, addressed to both the Bombay Stock Exchange and National Stock Exchange of India.

Board Meeting Details

The upcoming board meeting represents an update to the company's previous communication dated December 26, 2025. The January 21, 2026 filing specifically adds the consideration of interim dividend declaration to the board's agenda for the scheduled meeting.

Regulatory Compliance

The announcement was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Flavia Machado, serving as the company's authorized signatory, and was digitally authenticated on January 21, 2026.

Company Information

Procter & Gamble Hygiene and Health Care Limited operates with CIN L24239MH1964PLC012971 and maintains its registered office at P&G Plaza, Cardinal Gracias Road, Chakala, Andheri (E), Mumbai 400099. The company's shares are listed on major Indian stock exchanges with specific scrip codes for trading purposes.

Market Communication

The regulatory filing serves as an official update to stakeholders and the investment community regarding the board's expanded agenda. The company has requested stock exchanges to take note of this development and maintain it on record as part of standard disclosure procedures.